Publications by authors named "Juanxia Meng"

Claim this Profile
E
Early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapies.
Juanxia Meng, Hairong Lyu, Zhao Wang, Xue Bai, Haibo Zhu

Front Immunol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated data of CLL1 CAR-T cell therapy in adult patients with relapsed/refractory acute myeloid leukemia.
Xiaomei Zhang, Wenyi Lu, Wenjun Zhang, Xiaoyuan He, Yu Zhang, Meng Zhang, Juanxia Meng

J Hematol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
Meng Zhang, Xiaomei Zhang, Jiaxi Wang, Wenyi Lu, Xia Xiao, Juanxia Meng

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.
Qianyi Zhou, Yuxin An, Xiaomei Zhang, Xia Xiao, Xue Bai, Juanxia Meng, Haotian Meng

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-FcRL5 CAR-T exhibits anti-MM activity against EMM after progression of anti-BCMA and anti-GPRC5D CAR-T: a case report.
Xiaoyuan He, Xiaomei Zhang, Zhengyu Yu, Juanxia Meng, Yanyu Jiang

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte colony-stimulating factor in neutropenia management after CAR-T cell therapy: A safety and efficacy evaluation in refractory/relapsed B-cell acute lymphoblastic leukemia.
Xinping Cao, Meng Zhang, Ruiting Guo, Xiaomei Zhang, Rui Sun, Juanxia Meng

Chin Med J (Engl)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TTMV::RARA-positive acute promyelocytic leukemia with marrow necrosis and central nervous system involvement at disease recurrence.
Zhao Wang, Jiaqi Chen, Juanxia Meng, Mingfeng Zhao, Hongxing Liu

J Clin Exp Hematop· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation.
Wenyi Lu, Hairong Lyu, Xia Xiao, Xue Bai, Meng Zhang, Juanxia Meng, Haotian Meng

Leukemia· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-centers experience using therapeutic plasma exchange for corticosteroid/tocilizumab-refractory cytokine release syndrome following CAR-T therapy.
Yedi Pu, Yifan Zhao, Yuekun Qi, Yang Liu, Meng Zhang, Juanxia Meng

Int Immunopharmacol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells.
Xin Jin, Danni Xie, Rui Sun, Wenyi Lu, Xia Xiao, Juanxia Meng

Oncoimmunology· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose administration of prednisone has a good effect on the treatment of prolonged hematologic toxicity post-CD19 CAR-T cell therapy.
Jiaxi Wang, Meng Zhang, Hairong Lyu, Ruiting Guo, Xia Xiao, Juanxia Meng

Front Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metagenomic Next-Generation Sequencing for Diagnostically Challenging Mucormycosis in Patients with Hematological Malignancies.
Meng Zhang, Wenyi Lu, Danni Xie, Jiaxi Wang, Xia Xiao, Juanxia Meng

Infect Drug Resist· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure.
Meng Zhang, Zhao Wang, Jiaxi Wang, Hairong Lv, Xia Xiao, Juanxia Meng

Infect Drug Resist· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of second-time CAR-T 19 therapy after failure of first-time CAR-T 19 and ibrutinib therapy in relapsed mantle cell lymphoma.
Juan Mu, Meijing Liu, Jia Wang, Juanxia Meng, Rui Zhang

Adv Clin Exp Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients.
Wenyi Lu, Xin Jin, Hairong Lyu, Xue Bai, Haibo Zhu, Juanxia Meng, Meng Zhang

Cell Transplant· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the safety and efficacy of humanized anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma based on the comprehensive geriatric assessment system.
Huan Zhang, Man Liu, Qing Li, Cuicui Lyu, Yan-Yu Jiang, Juan-Xia Meng

Leuk Lymphoma· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease.
Wenyi Lu, Yunxiong Wei, Yaqing Cao, Xia Xiao, Qing Li, Juanxia Meng

Cancer Immunol Immunother· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Effect and Involved Mechanism of RSL3-induced Ferroptosis in Acute Leukemia Cells MOLM13 and Drug-resistant Cell Lines].
Lin Cheng, Xin Jin, Wen-Yi Lu, Rui Sun, Ya-Qing Cao, Juan-Xia Meng

Zhongguo Shi Yan Xue Ye Xue Za Zhi· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of humanized anti-CD19-CAR-T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia.
Jia Wang, Nan Mou, Zhenxing Yang, Qing Li, Yanyu Jiang, Juanxia Meng

Br J Haematol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of outcomes of haploidentical donor hematopoietic stem cell transplantation supported by third-party cord blood with HLA-matched unrelated donor transplantation.
Hairong Lyu, Wenyi Lu, Jianfeng Yao, Xia Xiao, Qing Li, Juanxia Meng

Leuk Lymphoma· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation.
Xin Jin, Yaqing Cao, Luqiao Wang, Rui Sun, Lin Cheng, Juanxia Meng

Leukemia· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-T 19 combined with reduced-dose PD-1 blockade therapy for treatment of refractory follicular lymphoma: A case report.
Jia Wang, Qi Deng, Yan-Yu Jiang, Rui Zhang, Hai-Bo Zhu, Juan-Xia Meng

Oncol Lett· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL.
Xiaoyuan He, Xia Xiao, Qing Li, Yanyu Jiang, Yaqing Cao, Juanxia Meng

Leukemia· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Exchange Can Be an Alternative Therapeutic Modality for Severe Cytokine Release Syndrome after Chimeric Antigen Receptor-T Cell Infusion: A Case Report.
Xia Xiao, Xiaoyuan He, Qing Li, Huan Zhang, Juanxia Meng

Clin Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice.
Xin Jin, Xiaoyuan He, Xiaoli Cao, Ping Xu, Yi Xing, Juanxia Meng

Haematologica· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis